-transparent.png){kind=logo}
The effect of valproic acid (VPA) on the disposition of carbamazepine-10,11-epoxide (epoxide) was studied in five epileptic patients on chronic carbamazepine (CBZ) therapy. The individual pharmacokinetic parameters influencing epoxide disposition were determined in the presence and absence of VPA. VPA significantly decreased the clearance of unbound epoxide (an in vivo index of epoxide hydrolase activity), but did not appear to affect epoxide formation. VPA also increased the free concentrations of both CBZ and epoxide.
Related Publications
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
June 1995,
Therapeutic drug monitoring,
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
July 2001,
Pediatric neurology,
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
January 2000,
Folia medica,
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
May 2018,
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
January 1989,
International journal of clinical pharmacology research,
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
February 2000,
Pharmaceutical research,
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
November 1978,
European journal of clinical pharmacology,
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
May 2005,
Journal of pediatric endocrinology & metabolism : JPEM,
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
June 1994,
British journal of clinical pharmacology,
D K Robbins, and
P J Wedlund, and
R Kuhn, and
R J Baumann, and
R H Levy, and
S L Chang
January 1990,
European neurology,
